Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
SK hynix to Showcase Energy-Efficient, High-Performance Memory Products at CES 2023 2022-12-27 07:30
CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans. 2022-12-26 21:00
Korea's top authenticity platform SWEBS enters US market 2022-12-21 22:00
Hyundai Mobis and Ottopia enter a partnership to introduce the world's first automotive grade remote assistance solution for OEMs and mobility service providers 2022-12-21 10:00
SK to Showcase 40 Carbon Reduction Technologies at CES 2023 2022-12-20 22:00
LG Innotek to come forward as the 'Total Solution Provider for future cars' in 'CES 2023' 2022-12-19 22:00
LG Innotek, developed two new hybrid lenses for high-performance Autonomous Driving 2022-12-19 14:39
GLN and KB Join Forces to Establish Global Payment Network 2022-12-19 08:00
Amorepacific Initiates Strategic Collaboration for New Beauty Research 2022-12-16 22:00
MORAI To Showcase Latest Autonomous Driving Simulation Technology at CES 2023 2022-12-16 22:00
Comedian, Actor & Host Howie Mandel Steps into the Metaverse powered by DeepBrain AI 2022-12-15 22:00
ZER01NE, Hyundai-Kia's Creative Talent Platform, to Showcase Innovative Startups at CES 2023 2022-12-15 22:00
Willog to unveil item-level condition visibility at CES 2023 2022-12-15 21:30
BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy 2022-12-15 21:00
Lunit AI Can Help Tuberculosis Screening in Prisons, as Published in The Lancet Regional Health - Americas 2022-12-15 21:00
LG Innotek, developed two new hybrid lenses for high-performance Autonomous Driving 2022-12-14 22:00
Vueron Technology to launch eco-friendly autonomously driven cold-chain delivery 2022-12-14 19:20
SK Biopharmaceuticals Unveils Vision for Digital Healthcare 2022-12-14 10:00
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab) 2022-12-12 21:00
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
1 52 53 54 55 56 161